Every Form 4 that Stryker Corporation (SYK) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SYK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SYK filings page.
Preston Wendell Wells reported disposition transactions in this Form 4 filing. Stryker Corp. VP, Chief Financial Officer Preston Wendell Wells transferred 109 common shares held in the Employee Stock Purchase Plan on September 24, 2026, pursuant to a Matrimonial Settlement Agreement. After the transfer, his reported direct holdings were 3,661 shares; he also held 310 shares indirectly through a 401(k).
STRYKER CORP (symbol: SYK) is the issuer of record for a Form 4 filing submitted to the SEC. Wells Preston Wendell reported disposition transactions in this Form 4 filing.
Wells Preston Wendell, Stryker Corp.'s VP, Chief Financial Officer, reported transferring 1,777 directly held common shares on July 17, 2026, and 962 on September 22, 2026, pursuant to a Matrimonial Settlement Agreement. A separate entry dated July 17, 2026 lists 310 common shares held indirectly through a 401(k). No Rule 10b5-1 plan is reported.
STRYKER CORP (SYK) director Mary K. Brainerd reported a series of indirect open‑market purchases of common stock associated with family accounts. On November 22, 2022, a trust for her husband purchased 18 shares at $225.195 per share; earlier purchases by the same trust and by her IRA between June 2019 and June 2020 totaled 131 shares. A separate line shows she held 7,790 shares directly as of June 26, 2019. No Rule 10b5‑1 trading plan is reported, and footnotes state that 11 shares initially bought in her IRA were later moved into her husband’s revocable trust on September 1, 2026.
STRYKER CORP (SYK) officer Dylan Bram Crotty, a Group President, reported selling 441 shares of common stock on 2026-08-21 at $328.605 per share. The sold shares were held indirectly through the Dylan B Crotty Trust. After this sale, the trust held 6,102 shares.
Crotty also reported separate holdings of 5,474 shares held directly, 1,509 shares held indirectly via a 401(k), and 313 shares each held indirectly for a daughter and a son.
STRYKER CORP (SYK) director Ronda E. Stryker reported open-market sales of 350,000 shares of common stock on August 18–19, 2026, through a revocable trust, at weighted average prices generally between $331.15 and $343.90 per share. After these transactions, she reports holdings of 12,177,521 shares indirectly via the L. Lee Stryker Trust, 37,600 shares indirectly via the 1988 William D. Johnston Trust, and 762 shares held directly.
STRYKER CORP (SYK) officer Debra King, VP and Chief Digital and Information Officer, reported selling 826 shares of common stock on 2026-08-18 in an open-market transaction at a weighted average price of $336.304 per share, with individual trade prices ranging from $336.255 to $336.304. Following this sale, she directly holds 6,210 shares of SYK common stock and indirectly holds 8 shares through a 401(k) plan.
STRYKER CORP officer Kimberly Ann Montagnino, VP, Chief Communications Officer, had 155 shares of Common Stock withheld on August 1, 2026 to satisfy exercise-price or tax-liability obligations at $325.70 per share, leaving 1,717 shares held directly plus 33 shares held indirectly through a 401(k).
Debra King, VP and Chief Digital and Information Officer of Stryker Corp, had 533 common shares withheld at $325.7000 per share on 2026-08-01 to cover an exercise price or tax liability. After this code F disposition she holds 7036 shares directly and 8 shares indirectly via a 401(k).
Stryker Corp executive Robert S. Fletcher, VP and Chief Legal Officer, reported a disposition of 94 shares of common stock on 2026-08-01 to pay an exercise price or tax liability at $325.70 per share. After this withholding, he holds 10,488 shares directly and 184 shares indirectly through a 401(k). The transaction was not reported under a Rule 10b5-1 trading plan.
Stryker Corp executive M Kathryn Fink, VP and Chief HR Officer, reported an F-code tax- or exercise-related disposition of 111 common shares on August 1, 2026 at $325.70 per share. After this withholding, she directly holds 13,027 shares, including 129 acquired through the Employee Stock Purchase Plan as of June 30, 2026, plus 177 shares held via the 2023 Mary Fink Living Trust and 445 shares held via a 401K.
Stryker Corp President and COO Spencer S. Stiles reported a bona fide gift of 1,607 shares of Common Stock. The shares were donated to a charitable donor advised fund and were transferred at a price of $0.00 per share, meaning there was no sale in the market.
After the gift, Stiles directly holds 76,027 shares of Stryker Common Stock and indirectly holds 1,693 shares through a 401(k) plan. The filing reflects a charitable disposition rather than a trading decision.
STRYKER CORP VP and Chief Legal Officer Robert S. Fletcher sold 4,544 shares of common stock in open-market transactions on May 28, 2026. Sale prices ranged from about $304 to $310 per share, with several trades reported at weighted average prices. The filing notes these sales were made under a Rule 10b5-1 trading plan adopted on February 26, 2026. After the transactions, he holds 10,582 shares directly and 183 shares indirectly through a 401(k) plan.
Stryker Corp director Ronda E. Stryker reported a series of open-market sales of the company’s Common Stock on May 26, 2026 through a Revocable Trust. The filing shows that the trust sold a total of 310,000 shares at weighted average prices ranging from about $310.35 to $315.69 per share. These are indirect transactions attributed to the Revocable Trust associated with the reporting person. Separate holding entries indicate she also has 1,322 shares held directly, 37,600 shares held indirectly through the 1988 William D. Johnston Trust, and 12,177,521 shares held indirectly through the L. Lee Stryker Trust as of the same date, highlighting that the reported sales represent a relatively small portion of her overall indirect ownership.
Stryker Corporation VP and Chief HR Officer M. Kathryn Fink reported a mix of stock option exercises, tax withholding, and open-market sales of Stryker common stock. On May 8, 2026, she exercised employee stock options to acquire 21,582 shares at exercise prices of $179.3500 and $154.1400 per share. On the same date, 16,362 shares were disposed of to satisfy tax obligations, which is recorded as a tax-withholding disposition rather than a market sale.
On May 11, 2026, 3,500 shares were sold in the open market at an average price of $283.4530 per share by the 2023 Mary Fink Living Trust, and 5,220 shares were sold directly at an average price of $283.8450 per share. After these transactions, Fink holds 13,137 shares directly, 444 shares indirectly through a 401(k), and 177 shares indirectly via the Living Trust, which includes 128 shares acquired under Stryker’s Employee Stock Purchase Plan as of March 31, 2026.
Suri Rajeev reported acquisition or exercise transactions in this Form 4 filing.
Stryker Corporation director Rajeev Suri received an equity award in the form of restricted stock units. On May 6, 2026, he was granted 762 RSUs that were reported as common stock, with no cash paid as this is compensation rather than a market purchase.
The RSUs will vest in full on the earlier of the company’s 2027 Annual Meeting of Shareholders or May 6, 2027. Each RSU represents a contingent right to receive one share of Stryker common stock. Following this grant, Suri directly owns 7,190 shares of Stryker common stock.
Stryker Corporation director Ronda E. Stryker received an equity award of 762 Restricted Stock Units (RSUs) of Stryker common stock. The award is compensation, not an open-market purchase, and increases her directly held shares to 1,322 after the grant.
The RSUs vest in full on the earlier of the company’s 2027 Annual Meeting of Shareholders or May 6, 2027, and each RSU converts into one share of common stock upon settlement. In addition to her direct holdings, she has significant indirect ownership through various trusts, including 37,600 shares held by the 1988 William D. Johnston Trust, 12,857,163 shares held by the L. Lee Stryker Trust, and 2,231,173 shares held by a revocable trust.
Skeete Tatum Lisa M reported acquisition or exercise transactions in this Form 4 filing.
Stryker Corporation director Lisa M. Skeete Tatum received an equity grant in the form of Restricted Stock Units (RSUs). She was awarded 762 shares of common stock at no stated purchase price, increasing her direct holdings to 5,205 shares after the grant.
The 762 RSUs vest in full on the earlier of the 2027 Annual Meeting of Shareholders of Stryker Corporation or May 6, 2027. Each RSU represents a contingent right to receive one share of Stryker common stock upon vesting, aligning a portion of the director’s compensation with future company performance and share price.
Silvernail Andrew K reported acquisition or exercise transactions in this Form 4 filing.
Stryker Corporation director Andrew K. Silvernail received an equity award of 762 Restricted Stock Units (RSUs) of Stryker common stock. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest 100% on the earlier of the 2027 Annual Meeting of Shareholders or May 6, 2027.
Silvernail has voluntarily elected to defer receipt of the shares issuable upon settlement of these RSUs until his departure from the Board of Directors. Following this grant, he directly holds 18,465 shares of Stryker common stock, indicating this is a modest, routine compensation-related award relative to his overall stake.
Stryker Corporation director Rachel Ruggeri received an equity award of 762 shares of Common Stock in the form of Restricted Stock Units (RSUs). The award was granted at no cash cost to her and is classified as a grant or other acquisition, not an open-market purchase.
The RSUs vest in full on the earlier of the date of Stryker’s 2027 Annual Meeting of Shareholders or May 6, 2027. Each RSU represents a contingent right to receive one share of Stryker Common Stock, and following this grant she holds 2,001 shares directly.
McCoy Sherilyn S reported acquisition or exercise transactions in this Form 4 filing.
STRYKER CORP director Sherilyn S. McCoy received an equity grant of 762 Restricted Stock Units. Each RSU represents a right to receive one share of Stryker common stock. The RSUs vest 100% on the earlier of the 2027 Annual Meeting of Shareholders or May 6, 2027.
McCoy has elected to defer settlement of these RSUs, so the corresponding Stryker shares will be delivered on May 1, 2031. After this grant, she holds 7,190 shares of Stryker common stock directly.
Stryker Corporation director Emmanuel Perez Maceda received an equity award in the form of Restricted Stock Units (RSUs). The award covers 762 shares of Stryker common stock and is recorded as a grant/award acquisition, not an open-market purchase or sale.
The RSUs vest in full on the earlier of the company’s 2027 Annual Meeting of Shareholders or May 6, 2027. Each RSU represents a contingent right to receive one share of Stryker common stock. Following this grant, Maceda directly holds 1,322 common shares.
Caforio Giovanni reported acquisition or exercise transactions in this Form 4 filing.
Stryker Corporation director Giovanni Caforio reported an equity award in the form of Restricted Stock Units (RSUs). On May 6, 2026, he received 762 RSUs, each representing a contingent right to one share of Stryker common stock. These RSUs vest 100% on the earlier of the 2027 Annual Meeting of Shareholders or May 6, 2027. Following this grant, Caforio directly holds 4,530 shares of Stryker common stock.
Stryker Corporation director Mary K. Brainerd received an equity award of 762 Restricted Stock Units (RSUs) on May 6, 2026. The grant is a form of stock-based compensation and carries no cash exercise price. After this award, she directly holds 7,790 shares of Stryker common stock.
The RSUs vest in full on the earlier of the 2027 Stryker annual meeting of shareholders or May 6, 2027. Each RSU converts into one share of Stryker common stock when it vests, aligning the director’s compensation with shareholder interests over this period.
Montagnino Kimberly Ann reported acquisition or exercise transactions in this Form 4 filing.
Stryker Corp reported an insider equity award for VP, Chief Communications Officer Kimberly Ann Montagnino. On May 6, 2026, she received 677 Restricted Stock Units (RSUs) of common stock as a compensation grant. These RSUs vest in three equal installments on May 1, 2027, May 1, 2028, and May 1, 2029. Each RSU represents the right to receive one share of Stryker common stock. Following this grant, Montagnino holds 1,872 shares of common stock directly and 33 shares indirectly through a 401(k) plan. The filing shows a routine, non-market grant rather than an open-market purchase or sale.
King Debra reported acquisition or exercise transactions in this Form 4 filing.
Stryker Corp officer Debra King received 1,016 Restricted Stock Units (RSUs) of common stock as equity compensation. The RSUs were granted at no cash cost and increase her direct holdings to 7,569 shares of Stryker common stock, with an additional 8 shares held indirectly through a 401(k) plan.
The 1,016 RSUs vest in three equal installments: one-third on May 1, 2027, one-third on May 1, 2028, and the remaining one-third on May 1, 2029. Each RSU represents a contingent right to receive one share of Stryker common stock as it vests.
Stryker Corp President and COO Spencer S. Stiles reported routine equity compensation activity. On March 21, 2026, dividend equivalents tied to previously earned performance stock units vested, and 430 Dividend Equivalents were exercised and settled into 430 shares of Common Stock.
To cover related tax obligations, 6,690 shares of Common Stock were disposed of at $335.67 per share through share withholding, not an open-market sale. After these entries, Stiles directly holds 77,634 Common Stock shares and indirectly holds 1,670 shares through a 401(k) plan, indicating a continuing substantial ownership position.
Stryker Group President James Andrew Pierce reported routine equity compensation activity tied to previously earned performance stock units. On March 21, 2026, 430 dividend equivalent units were converted into an equal number of Stryker common shares, while 7,807 shares were delivered to cover tax obligations. Following these transactions, Pierce holds 80,869 Stryker common shares directly, plus indirect holdings of 712 shares through Son GP, 713 shares through Son AP, and 1,595 shares through a 401(k) account.
Stryker Group President Viju Menon reported routine equity compensation activity. Dividend equivalents tied to previously earned performance stock units were exercised into 269 shares of Common Stock, while 4,718 shares were withheld at $335.67 per share to cover tax obligations. Following these entries, he directly holds 17,382 shares, plus 198 shares indirectly through a 401(k).
Stryker Corporation Chair and CEO Kevin Lobo reported routine equity compensation activity tied to previously earned performance stock units. He exercised dividend-equivalent rights into 1,452 shares of common stock and, in a separate transaction, 26,492 shares were withheld at $335.67 per share to cover tax obligations. After these transactions, he holds 222,231 common shares directly and 721 shares indirectly through a 401(k) plan.
Stryker Corp VP and Chief Legal Officer Robert S. Fletcher reported compensation-related stock activity tied to prior performance awards. On March 21, 2026, he exercised 225 dividend equivalent units linked to previously earned Performance Stock Units, receiving an equal number of Stryker Common Stock shares at no cost.
On the same date, 3,384 Common Stock shares were disposed of at $335.67 per share to cover tax obligations, a non-market transaction coded as tax withholding. After these entries, Fletcher directly holds 15,126 Common Stock shares and indirectly holds 162 shares through a 401(k) plan.
Stryker Corp vice president and Chief HR Officer M. Kathryn Fink reported routine equity compensation activity. Dividend-equivalent rights tied to previously earned performance stock units were exercised into 150 shares of common stock on March 21, 2026, and settled at no exercise price.
On the same date, 2,064 shares of common stock were disposed of at $335.67 per share to cover tax obligations, leaving Fink with 16,637 shares of Stryker common stock held directly. Additional indirect holdings include 422 shares held through a 401(k) plan and 177 shares held by the 2023 Mary Fink Living Trust.
Stryker Corporation VP and Chief Financial Officer Preston Wendell reported a routine tax-related share disposition. On the reported date, 204 shares of common stock were withheld at $335.67 per share to satisfy tax obligations, a non-market transaction. After this, he held 6,498 shares directly and 288 shares indirectly through a 401(k) plan, which includes shares acquired under the ESPP and PIA plans as of December 31, 2025.
Stryker Group President Dylan Bram Crotty reported a routine tax-related share disposition. On March 21, 2026, 368 shares of Stryker common stock were withheld at $335.67 per share to cover tax obligations, leaving 5,474 shares held directly. He also reports indirect holdings of 1,480 shares in a 401(k), 6,543 shares in a personal trust, and 313 shares each held for a daughter and son.
Stryker VP and Chief Accounting Officer William E. Berry Jr. reported a routine tax-related share disposition. On March 21, 2026, 176 shares of Stryker common stock were used at $335.67 per share to satisfy tax obligations, a non‑market transaction. After this, he holds 3,426 shares directly and 615 shares indirectly through a 401(k) plan.
Stryker Corp Chair and CEO Kevin Lobo received an equity award of 50,332 shares of Common Stock on March 9, 2026 as a grant/award acquisition. The award was earned upon achieving pre-set three-year adjusted diluted net earnings per share goals and sales performance goals, and the earned shares vest on March 21, 2026.
After this award, Lobo directly holds 247,271 shares of Stryker common stock and indirectly holds 721 shares through a 401(k) plan. A one‑share adjustment corrected a previously reported balance related to an earlier option exercise and associated tax withholding.
Stryker Corporation reported that VP and Chief HR Officer M. Kathryn Fink received a grant of 5,220 shares of common stock on March 9, 2026 as a compensation award at $0.00 per share. The award was earned upon achievement of pre-established three-year adjusted diluted net earnings per share and sales performance goals, and the earned shares vest on March 21, 2026. Following this award, Fink directly holds 18,551 shares, with additional indirect holdings of 422 shares through a 401(k) plan and 177 shares through the 2023 Mary Fink Living Trust. The direct holdings include 128 shares acquired under Stryker's Employee Stock Purchase Plan as of December 31, 2025.
Fletcher Robert S reported acquisition or exercise transactions in this Form 4 filing.
STRYKER CORP VP and Chief Legal Officer Robert S. Fletcher reported an equity award of 7,828 shares of Common Stock. The shares were granted at no cash cost as compensation after the achievement of pre-established three-year adjusted diluted net earnings per share and sales performance goals, and will vest on March 21, 2026. Following this award, he directly holds 18,285 common shares, and indirectly holds 162 shares through a 401(k) plan.
STRYKER CORP Group President Viju Menon reported a compensation-related stock award, not an open-market purchase. He acquired 9,320 shares of common stock at no cost as a grant tied to pre-established three-year adjusted diluted net earnings per share and sales performance goals.
The earned shares are scheduled to vest on March 21, 2026. Following this grant, Menon holds 21,831 shares directly and 198 shares indirectly through a 401(k) plan, giving a clearer picture of his overall equity stake in the company.
Stryker Corp President and COO Spencer S. Stiles reported an acquisition of 14,912 shares of Common Stock as a performance-based award. The shares were earned upon meeting pre-established three-year adjusted diluted net earnings per share and sales performance goals and will vest on March 21, 2026.
After this grant, Stiles directly holds 83,894 Stryker shares and has an additional 1,670 shares held indirectly through a 401(k) plan. This filing reflects executive compensation rather than an open-market stock purchase or sale.
Pierce James Andrew reported acquisition or exercise transactions in this Form 4 filing.
Stryker Corp Group President James Andrew Pierce reported an equity award of 14,912 shares of Common Stock. The shares were granted at no cash cost upon achievement of pre-set three-year earnings per share and sales goals and will vest on March 21, 2026.
After this grant, Pierce directly holds 88,246 common shares. He also reports indirect holdings of 712 shares held by "Son GP", 713 shares held by "Son AP", and 1,595 shares held through a 401(k) account as of the same date.
STRYKER CORP director Ronda E. Stryker reported a bona fide gift of 55,600 shares of common stock on behalf of a revocable trust. The trust held 2,231,173 shares after the gift. Additional indirect holdings were 12,857,163 shares in the L. Lee Stryker Trust and 37,600 shares in the 1988 William D. Johnston Trust, plus 560 shares held directly.
Stryker Corp director Ronda E. Stryker reported several indirect trust transactions in company common stock. A revocable trust associated with her made bona fide gifts of 377,900 shares on February 13, 2026 and 222,300 shares on February 17, 2026, both at a stated price of $0.00 per share.
Separately, on February 17, 2026, the L. Lee Stryker Trust, for which she serves as trustee and her children are beneficiaries, distributed 42,000 shares to beneficiaries’ individual trusts. She disclaims beneficial ownership of the L. Lee Stryker Trust holdings except to the extent of her pecuniary interest.
Stryker Corporation director Ronda E. Stryker, through a revocable trust, reported a series of open-market sales of Stryker common stock on February 4–5, 2026. The revocable trust sold multiple blocks of shares at weighted average prices ranging from $358.005 to $368.635 per share, as detailed in the footnotes. After these transactions, the revocable trust held 2,207,331 Stryker shares, with additional indirect holdings of 13,578,805 shares by the L. Lee Stryker Trust and 37,600 shares by the 1988 William D. Johnston Trust, plus 560 shares held directly.
Stryker Corporation reported an equity award transaction for VP and Chief Accounting Officer William E. Berry Jr. on February 4, 2026. He received a grant of 797 restricted stock units with no cash price per unit, increasing his directly held common stock to 3,602 shares, plus 615 shares held indirectly through a 401(k) plan.
Each RSU represents a contingent right to receive one share of Stryker common stock and is scheduled to vest in three equal installments on March 21, 2027, March 21, 2028, and March 21, 2029. Berry also received an employee stock option for 2,391 shares at an exercise price of $360.82, which becomes exercisable as to 20% of the option on each of the first five anniversaries of the grant date and expires on February 3, 2036.
Stryker Corporation reported that VP and Chief Commercial Officer Kimberly Ann Montagnino received an employee stock option grant on February 4, 2026. The option covers 1,830 shares of Stryker common stock at an exercise price of $360.82 per share.
The grant was issued under the Stryker Corporation 2011 Long-Term Incentive Plan and is exercisable as to 20% of the option on each of the first five anniversaries of the grant date. Following this award, she directly holds options for 1,830 shares.
Stryker Corporation reported that officer Debra King received a new stock option award. On February 4, 2026, she was granted 3,992 employee stock options with an exercise price of $360.82 per share under the Stryker Corporation 2011 Long-Term Incentive Plan.
The options vest in stages, becoming exercisable as to 20% on each of the first five anniversaries of the grant date, and are scheduled to expire on February 3, 2036. After this grant, King beneficially owns 3,992 derivative securities directly as VP, Chief Digital and Information Officer.
Stryker Corporation reported that VP and Chief HR Officer M. Kathryn Fink received an employee stock option award. On 02/04/2026 she was granted options to purchase 5,654 shares of Stryker common stock at an exercise price of $360.82 per share.
These options vest in stages, with 20% becoming exercisable on each of the first five anniversaries of the grant date, and they expire on 02/03/2036. The grant was made under the Stryker Corporation 2011 Long-Term Incentive Plan and is held directly by the executive.
Stryker Corporation granted a new stock option award to its VP and Chief Legal Officer, Robert S. Fletcher. On 02/04/2026, he received an employee stock option for 8,980 shares of Stryker common stock at an exercise price of $360.82 per share.
The option was granted under the Stryker Corporation 2011 Long-Term Incentive Plan and becomes exercisable as to 20% on each of the first five anniversaries of the grant date, creating a five-year vesting schedule tied to continued service.
Stryker Corporation granted stock options to senior executive Dylan Bram Crotty, its Group President. On 02/04/2026, he received an employee stock option for 9,978 shares of common stock at an exercise price of $360.82 per share, held directly.
The option was granted under the Stryker Corporation 2011 Long-Term Incentive Plan and becomes exercisable as to 20% of the shares on each of the first five anniversaries of the grant date, with an expiration date of 02/03/2036.
Stryker Corporation reported that Group President Viju Menon received an employee stock option grant on February 4, 2026. The award covers 10,310 options to buy Stryker common stock at an exercise price of $360.82 per share.
These options were granted under the Stryker Corporation 2011 Long-Term Incentive Plan and become exercisable in stages, with 20% vesting on each of the first five anniversaries of the grant date. Following this grant, Menon beneficially owns 10,310 derivative securities directly in the form of these options.